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Abstract 34 
Objective: To assess the association between vaginal microbiome (VMB) composition and 35 
recurrent early spontaneous preterm birth (sPTB)/preterm prelabour rupture of membranes 36 
(PPROM).  37 
Design: Nested case-control study. 38 
Setting: UK tertiary referral hospital. 39 
Sample: High-risk women with previous sPTB/PPROM <34
+0
 weeks gestation who had a 40 
recurrence (n=22) or delivered at ≥37
+0
 weeks without PPROM (n=87). 41 
Methods: Vaginal swabs collected between 15-22 weeks gestation were analysed by 16S 42 
rRNA gene sequencing and 16S quantitative PCR. 43 
Main outcome measure: Recurrent early sPTB/PPROM. 44 
Results: 28/109 high-risk women had anaerobic vaginal dysbiosis, with the remainder 45 
dominated by lactobacilli (L. iners 36/109, L. crispatus 23/109, or other 22/109). VMB type, 46 
diversity, and stability were not associated with recurrence. Women with a recurrence, 47 
compared to those without, had a higher median vaginal bacterial load (8.64 vs. 7.89 log10 48 
cells/μl, adjusted odds ratio (aOR)=1.90, 95% confidence interval (CI)=1.01-3.56, p=0.047) 49 
and estimated Lactobacillus concentration (8.59 vs. 7.48 log10 cells/μl, aOR=2.35, CI=1.20-50 
4.61, p=0.013). A higher recurrence risk was associated with higher median bacterial loads 51 
for each VMB type after stratification, although statistical significance was reached only for 52 
L. iners-domination (aOR=3.44, CI=1.06-11.15, p=0.040). Women with anaerobic dysbiosis or 53 
L. iners-domination had a higher median vaginal bacterial load than women with a VMB 54 
dominated by L. crispatus or other lactobacilli (8.54, 7.96, 7.63, and 7.53 log10 cells/μl, 55 
respectively).  56 
Conclusions: Vaginal bacterial load is associated with early sPTB/PPROM recurrence. 57 
Domination by lactobacilli other than L. iners may protect women from developing high 58 
bacterial loads. Future PTB studies should quantify vaginal bacteria and yeasts. 59 
Funding: Wellbeing of Women, London, UK 60 
Keywords: vaginal microbiome; Lactobacillus; spontaneous preterm birth; preterm 61 
premature rupture of membranes. 62 
Tweetable abstract: Increased vaginal bacterial load in the second trimester may be 63 
associated with recurrent early spontaneous preterm birth.   64 
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Introduction  65 
Previous spontaneous preterm birth (sPTB) or preterm prelabour rupture of membranes 66 
(PPROM) is the strongest risk factor for recurrent sPTB/PPROM.
1
  This may implicate a 67 
genetic contribution
2
 but does not rule out a contribution of persistent microbes and/or 68 
inflammation in the female reproductive tract.
3
  69 
 70 
16S ribosomal RNA (16S rRNA) sequencing was first used to assess the relationship between 71 
the bacterial vaginal microbiota (VMB) and PTB in 2014.
4
 Since then over 2000 pregnant 72 
women have been assessed in 12 studies (Appendix A, Table A1) . The majority of these 73 
studies suggested a contribution of the VMB composition to PTB, but results have been 74 
inconsistent. The healthy vagina in pregnancy is dominated by Lactobacillus species but 75 
contains up to 80 different Lactobacillus and other bacterial taxa, and the optimal ways of 76 
summarising and categorising sequencing data to determine clinically relevant associations 77 
with PTB are yet to be determined.
5,6
  Studies to date have shown that increased relative 78 
abundances of L. crispatus, L. gasseri, and L. jensenii were either not associated with PTB or 79 
associated with a reduced PTB risk, and increased relative abundances of bacterial vaginosis 80 
(BV)-associated anaerobes were either not associated with PTB or associated with an 81 
increased PTB risk (Table A1).  Results for L. iners relative abundance were inconsistent, with 82 
6 studies showing no association, two studies an increased risk, and one study a decreased 83 
risk (Table A1). Importantly, all studies except two
7,8
 relied on compositional data, meaning 84 
that an increase in the proportion of one taxon always leads to a decrease in the proportions 85 
of other taxa.
9
 Furthermore, an increase in a proportion does not necessarily indicate an 86 
increase in absolute quantity. VMB researchers have only recently begun to semi-quantify 87 
16S rRNA sequencing data by combining sequencing data with a quantitative PCR (qPCR) of 88 
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the 16S rRNA gene.
10
 The two studies to date that included some quantification reported 89 
opposite results, with one reporting a positive association between overall vaginal bacterial 90 
load and PTB risk,
7






Our aim was to assess associations between VMB compositions and recurrent early 93 
sPTB/PPROM (delivery at <34
+0
 weeks compared to delivery at ≥37
+0
 weeks) among high-risk 94 
pregnant women who had had a previous early sPTB/PPROM, using compositional and semi-95 




Study design and population 100 
Two cohorts of women at high and low-risk of PTB were enrolled at Liverpool Women’s 101 
Hospital, UK, from 1 June 2015 until 31 December 2017. The hospital’s patient and public 102 
engagement group helped guide the research and recruitment (Appendix A). High-risk was 103 




 weeks gestation, and low-risk as having 104 
had at least one previous term birth (≥37
+0
 weeks) without PPROM and never having had a 105 
PTB or PPROM. In the low-risk cohort, but not in the high-risk cohort, women were excluded 106 
if they had had significant cervical surgery or previous obstetric or medical problems 107 
(Appendix A). For this nested case-control study, we selected 109 women from the high-risk 108 
cohort (N=137) and 145 women from the low-risk cohort (N=223) based on the pregnancy 109 




weeks or birth ≥37
+0 
weeks in the high-risk cohort and 110 
birth ≥39
+0 
weeks in the low-risk cohort) and availability of valid VMB data (Figure 1). Birth 111 
outcomes were classified independently by two obstetricians experienced in PTB 112 
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management. When there was a discrepancy between them, the case was reviewed by a 113 
third experienced obstetrician until the team reached consensus. Participants with medically 114 
indicated PTBs, or for whom it was unclear whether a birth was truly spontaneous, were 115 
excluded. We used relevant parts of the CROWN initiative core outcome set for PTB 116 
research
11
 (Appendix A). 117 
 118 
Clinical procedures 119 




 weeks) 120 




) gestation. At each visit, a study obstetrician interviewed the 121 
participant; collected high vaginal swabs during a speculum examination for VMB 122 
assessments at the University of Liverpool Center for Genomic Research (HydraFlock 123 
standard tapered swabs, Medical Wire and Equipment, Corsham, UK) and for quantitative 124 
assessment of foetal fibronectin and culture by the local NHS laboratory; determined 125 
cervical length; and did a 3D foetal ultrasound. All other procedures during pregnancy, and 126 
all treatments, were in accordance with UK national guidelines.
12
 Preterm birth prevention 127 
therapy (cerclage, vaginal pessary, or vaginal progesterone) was offered if cervical length 128 
was ≤ 25mm or based on clinician and patient preference in case of a large change in cervical 129 
length between measurements. None of the low-risk women required an intervention but 130 
71.6% (78/109) of the high-risk women did (Table 1). Initiation of this treatment was always 131 
after the VMB sampling visits. 132 
 133 
VMB laboratory assessments 134 
DNA was extracted from one swab per woman per visit using lysozyme lysis and bead-135 
beating procedures combined with the Qiagen DNeasy Blood and Tissue kit (Qiagen, 136 
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Manchester, UK) (Appendix A).
13
  The V3-V4 region of the 16S rRNA gene was amplified and 137 
sequenced on an Illumina HiSeq 2500 instrument (Illumina, San Diego, CA) run in rapid 138 
mode, 2x300bp using a 250PE and 50E kit. The panbacterial 16S rRNA gene copy 139 
concentration per sample was determined using the BactQuant quantitative PCR (qPCR) 140 
assay.
14
 Molecular data processing steps are described in Appendix A. 141 
 142 
We only used the first set of valid sequencing results for each participant in the analyses 143 
because of the short time period between the two study visits, with one exception. In the 144 
subset of participants with valid sequencing results for both visits (88 high-risk and 129 low-145 
risk women) we used data from both visits for the VMB stability analyses.  146 
 147 
Creation and selection of VMB variables 148 
Existing approaches 149 
We systematically reviewed the published literature to identify VMB variables that were 150 
associated with PTB in at least one study (Appendix A, Table A1). These included: richness 151 
and Simpson diversity (1-D) as continuous variables; two categorical VMB composition 152 
variables with each participant assigned to one category (the community state types (CSTs) 153 
described by Ravel et al
15
 and Lactobacillus groups (dominant, intermediate, and deplete) 154 
based on Lactobacillus relative abundance);
16
 stability groups, slightly modified from Romero 155 
et al;
17
 and the presence/absence of specific taxa of interest (listed in Table A1).  156 
 157 
New approaches 158 
The final three sets of VMB variables are based on our previous work and were applied to 159 
PTB research for the first time.
18–21
 The first is a categorical VMB composition variable that 160 
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we named ‘VMB type’. These VMB types are similar to Ravel’s CSTs
15
 but with an increased 161 
emphasis on the relative abundance of pathobionts (Appendix A). We defined pathobionts 162 
as bacteria that are considered more pathogenic than BV-anaerobes and that often co-occur 163 
with lactobacilli instead of BV-anaerobes, such as streptococci. Secondly, each non-minority 164 
amplicon sequence variant (ASV; equivalent to a taxon) in each sample was allocated to one 165 
of four ‘bacterial groups’ based on the published literature (Appendix B): lactobacilli; BV-166 
anaerobes; pathobionts; and a rest group of ‘other bacteria’.
20
 Within each sample, read 167 
counts of ASVs belonging to the same bacterial group were summed. This resulted in four 168 
continuous relative abundance variables (one for each bacterial group) per sample, which 169 
sum to 1.0 for each sample. Finally, we converted these bacterial group relative abundances 170 
into estimated concentrations (again four continuous variables, one for each bacterial 171 
group) making use of the BactQuant results (Appendix A). The BactQuant data were also 172 
used to determine estimated concentrations of taxa of interest (listed in Table A1) and the 173 
total bacterial load in each sample.  174 
 175 
Statistical analysis 176 
Our primary comparisons were between high-risk women who gave birth ≥37
+0
 weeks 177 
gestation and high-risk women who had a recurrent early sPTB or PPROM <34
+0
 weeks. Low-178 
risk women who delivered at ≥39
+0
 weeks gestation without PPROM were used as the 179 
normal reference group because we had never before characterised VMB compositions in 180 
pregnant women residing in Liverpool. Characteristics between these three groups were 181 
compared by student’s t-test for age, Mann-Whitney U test for other continuous variables, 182 
and Fisher’s exact test for binary and categorical variables. The various VMB variables 183 
described above were compared between the two high-risk groups using unadjusted and 184 
adjusted logistic regression, with adjustments for body mass index (BMI; as a quadratic term 185 
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due to the bimodal association with PTB), history of cervical surgery (none, single LLETZ, or 186 
multiple LLETZ or knife cone biopsy), and smoking at the time of enrolment (yes/no). 187 
Quartiles of the expected distributions of total vaginal bacterial load and total estimated 188 
Lactobacillus concentration were generated using data from the low-risk reference group, 189 
and high-risk participants were allocated to one of these quartiles. These newly created 190 
categorical variables were also compared between the two high-risk groups of interest by 191 
logistic regression. Finally, in an effort to differentiate between the effects of total vaginal 192 
bacterial load and the types of bacteria that make up this load, women were stratified by 193 
VMB type, and the logistic regression analyses were repeated for each stratum.   194 
 195 
Results 196 
We recruited 137 high-risk women and 223 low-risk women. Of 131 high-risk women with 197 
VMB data that passed quality control, 22 had a recurrent early sPTB/PPROM and 87 had 198 
term births ≥37
+0
 weeks without PPROM (Figure 1); the remaining women were excluded 199 




 weeks or had a birth initiated by a caregiver. 200 
Of 214 low-risk participants with VMB data that passed quality control, 145 gave birth at 201 
≥39
+0
 weeks without PPROM and were used as the normal reference group. 202 
 203 
The participant characteristics of the three groups were similar (Tables 1 and A2), except for 204 
those that are known risk factors for sPTB/PPROM: a higher proportion of high-risk women 205 
with a recurrence, compared to those who delivered at term, had two or more previous 206 
early sPTB/PPROM events (31.8% vs. 9.2%) and multiple previous LLETZ or knife cone 207 
biopsies (13.6% vs. 1.1%). The median gestational age when the first valid VMB sample was 208 
taken was slightly later in the low-risk group (16
+5
 weeks) than in the high-risk group (16
+3
 209 
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weeks).  210 
 211 
VMB compositions and vaginal bacterial loads in high- and low-risk pregnant women 212 
The VMBs of over 70% of pregnant women, high- and low-risk, were dominated by 213 
lactobacilli (defined as ≥75% relative abundance; Tables 2 and A3, heatmap in Figure A1). L. 214 
iners domination was most common overall (VMB type Li; 33.0% of high-risk and 22.1% of 215 
low-risk pregnant women), followed by L. crispatus domination (VMB type Lcr; 21.1% and 216 
26.9%), and either domination by other lactobacilli (most commonly L. gasseri or L. jensenii) 217 
or ≥50% bifidobacteria (VMB type Lo+BL; 20.1% and 25.5%). In addition, 12.4% of high-risk 218 
and 12.8% of low-risk women had mild anaerobic dysbiosis (VMB type LA; defined as 25%-219 
75% lactobacilli with the remainder BV-anaerobes), and 12.8% of high-risk and 13.1% of low-220 
risk women had severe anaerobic dysbiosis (VMB type BV; ≥75% BV-anaerobes). Pathobionts 221 
and ‘other bacteria’ were rarely present, and if present, only in low relative abundance or 222 
estimated concentration (Tables 2 and A3).  223 
 224 





 weeks gestation was stable (Table 2). About two thirds of the high-risk (65.9%) 226 
and low-risk women (64.3%) were dominated by the same Lactobacillus species at both 227 
visits, and 14.8% of high-risk and 22.5% of low-risk women continued to have some degree 228 
of anaerobic dysbiosis. The remaining women switched Lactobacillus species (n=5) or shifted 229 
from lactobacilli-domination to anaerobic dysbiosis (n=12) or vice-versa (n=17). 230 
 231 
The median vaginal bacterial load in the low-risk reference cohort was 7.68 log10 cells/μl 232 
(interquartile range (IQR) 6.80-8.35) and in the high-risk cohort 8.07 (IQR 7.28-8.92) log10 233 
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cells/μl (Table 2). High-risk women with mild or severe anaerobic dysbiosis (pooled together) 234 
had higher median vaginal bacterial loads than women with domination by L. iners, L. 235 
crispatus, or other lactobacilli/bifidobacteria (8.54, 7.79, 7.63, 7.53 log10 cells/μl, 236 
respectively; p-values are <0.05 for all comparisons between dysbiosis and the other groups, 237 
but are not significant for the comparisons between L. iners-domination and the other two 238 
lactobacilli groups; Table A4).  239 
 240 
Associations with early sPTB/PPROM recurrence – existing approaches 241 
In the high-risk women, we did not identify any associations between recurrence and VMB 242 
richness, Simpson (1-D) diversity, CSTs,
15
 categorical Lactobacillus groups,
16
 categorical 243 
stability groups
17
 (Table 2), and presence or relative abundance of common Lactobacillus 244 
species (Table A3). Ureaplasma species and BVAB TM7-H1 were present in higher 245 
proportions of high-risk women with a recurrence than in high-risk women with a term birth, 246 
and Dialister species vice versa, but their relative abundances when present were very low 247 
(Table A3). In contrast, Bifidobacterium breve was present in a lower proportion of women 248 
with a recurrence, but its relative abundance when present was also low. The proportions of 249 
low-risk women with these taxa present were similar to those in high-risk women without a 250 
recurrence (Table A3, Figure A2A).  251 
 252 
Associations with early sPTB/PPROM recurrence – new approaches 253 
We did not identify any associations between recurrence and VMB type or estimated BV-254 
anaerobes or pathobionts concentrations (Table 2). However, high-risk women with a 255 
recurrence had a higher overall vaginal bacterial load (8.64 vs. 7.89 log10 cells/μl, adjusted 256 
odds ratio (aOR) 1.90, 95% confidence interval (CI) 1.01-3.56, p=0.047) and a higher total 257 
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estimated Lactobacillus concentration (8.59 vs. 7.48 log10 cells/μl, aOR 2.35, 95% CI 1.20-258 
4.61, p=0.013) than high-risk women without a recurrence (Table 2). The aOR was 1.63 (95% 259 
CI 0.93-2.86, p=0.093) for each increase in total vaginal bacterial load quartile, and 2.61 (95% 260 
CI 1.27-5.33, p=<0.001) for each estimated Lactobacillus concentration quartile (Table 2).  261 
 262 
Table 3 shows estimated concentrations of total vaginal bacteria, the four bacterial groups, 263 
L. cripatus, L. iners, and other lactobacilli in high-risk women with and without a recurrence 264 
after stratification by VMB type. A trend towards higher recurrence risk with higher median 265 
bacterial loads was seen for each VMB type after stratification but was only significant in 266 
women with L. iners-domination: the median vaginal bacterial loads were 9.03 (IQR 8.02-267 
9.12) log10 cells/μl in women with a recurrence compared to 7.79 (IQR 6.93-8.65) log10 268 
cells/μl in women with a term birth (aOR 3.44, 95%CI 1.06-11.15, p=0.011). The association 269 
was no longer significant after adjustment for confounders (aOR 2.38, 95%CI 0.71-7.95, 270 
p=0.160). Within each of the other VMB type strata, the median estimated concentrations in 271 
high-risk women who had a term birth were similar to those in low-risk women, and non-272 
significantly lower than those in high-risk women who had a recurrence. 273 
 274 
The majority of high-risk participants with an early sPTB/PPROM recurrence (17/22; 77.3%), 275 
and about half of the high-risk participants without a recurrence (44/87; 50.6%), had at least 276 
one VMB characteristic that was positively associated with recurrence. The following 277 
positively associated VMB characteristics overlapped considerably in both high-risk groups 278 
(Venn diagrams in Figure A2): highest quartile of total bacterial load, highest quartile of 279 
estimated total Lactobacillus concentration, highest quartile of estimated L. iners 280 
concentration, and presence of BVAB TM7-H1. The only positively associated VMB 281 
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characteristic that did not completely overlap with the highest quartile of bacterial and 282 
estimated total Lactobacillus concentration was the presence of Ureaplasma species (this 283 
was the case in high-risk pregnancies with and without a recurrence).  284 
 285 
Discussion 286 
Main Findings 287 
This exploratory study suggests that high vaginal bacterial load in the second trimester is 288 
associated with early sPTB/PPROM recurrence in high-risk pregnant women, irrespective of 289 
the bacterial composition. Our statistical power was limited: only 22 women had an early 290 
sPTB/PPROM recurrence. Therefore, not all associations in line with this conclusion reached 291 
statistical significance, especially after reducing statistical power further by stratification. 292 
However, we believe that this new hypothesis warrants further research for various reasons. 293 
First, the recurrence risk increased for each increase in bacterial and Lactobacillus 294 
concentration quartile (on a log10 scale). Second, the findings were consistent for each VMB 295 
type after stratification: higher recurrence in high-risk women with higher median bacterial 296 
loads for all VMB types (reaching significance for L. iners-domination), and similar median 297 
bacterial loads in high-risk and low-risk women who had a term birth for all VMB types. 298 
Third, estimated concentrations reached higher levels for anaerobic dysbiosis and L. iners-299 
domination than for domination by other lactobacilli or bifidobacteria. Our findings 300 
therefore do not contradict earlier findings by other groups that indicated increased PTB risk 301 
for anaerobic dysbiosis and high L. iners relative abundance.
8,22–24
 In fact, the inconsistent 302 
findings related to L. iners in the literature might be due to the lack of quantification in most 303 
studies. 304 
 305 
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Interpretation in light of other evidence  306 
To our knowledge, the potential association between the vaginal bacterial load and PTB has 307 
only been assessed in two previous studies. Freitas et al
7
 also showed a higher 16S gene 308 
concentration in the second trimester (approximately 16 weeks gestation) in women who 309 
had an sPTB <37 weeks compared to women with a term birth ≥37 weeks (8.1 vs. 7.8 log10 310 
copies/swab, respectively). Conversely, Elovitz et al
8
 reported a similar 16S gene 311 
concentration in women who had a sPTB <37 weeks compared to women with a term birth 312 
≥37 weeks in samples collected before 24 weeks gestation (approximately 8 log10 313 
copies/swab in each group), and a lower concentration (approximately 7.5 vs 7.9 log10 314 
copies/swab) in samples collected at 28 weeks gestation. High vaginal bacterial load may 315 
only be associated with PTB when present prior to 24 weeks gestation, but additional 316 
quantitative studies are needed.  317 
 318 
Female genital tract inflammation is considered one potential cause of PTB.
25 
BV (a clinical 319 
condition caused by anaerobic dysbiosis) is associated with vaginal inflammation, and is a 320 
very common condition in non-pregnant women.
26 
Pregnant women are protected from BV 321 
due to the high oestrogen levels during pregnancy.
27,28
 In our study, the prevalence of 322 
anaerobic dysbiosis, and the relative abundances and estimated concentrations of BV-323 
associated bacteria and pathobionts, were indeed low. This likely explains why we did not 324 
identify any statistically significant associations between the presence or extent of anaerobic 325 
dysbiosis and early sPTB/PPROM recurrence. However, the non-significant trends 326 
consistently suggested increased risk. Another common inflammatory vaginal condition is 327 
vulvovaginal candidiasis, for which pregnant women are at increased risk.
29
 In our study, 328 
only one woman (low-risk) reported having been treated for vulvovaginal candidiasis prior to 329 
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study enrolment. Future studies should systematically assess vaginal yeasts concentrations 330 
in addition to bacterial concentrations in all participants, and determine their potential 331 
contributions to early sPTB/PPROM recurrence. 332 
 333 
In our study, L. iners was able to achieve higher bacterial loads than the other lactobacilli, 334 
and was associated with early sPTB/PPROM recurrence. L. iners has a genome of just 1.3 335 
Mbp,
30
 strikingly smaller than the other common vaginal Lactobacillus species, and seems 336 
fully adapted to the vaginal niche.
31
 This may explain why it is able to grow to such high 337 
densities in the vagina. Lactobacillus species are considered to be non-inflammatory when 338 
present in the vagina,
32
 but they might cause inflammation when they travel through the 339 
cervical mucus plug into the upper genital tract. Ascension to the upper genital tract may be 340 
increased when vaginal density is high. Studies have shown that L. iners with high expression 341 
of clustered regularly inter-spaced short palindromic repeat (CRISPR) genes are present in 342 
women with BV but not in women without BV.
33
 CRISPR genes are the primary bacterial 343 
defence against bacteriophages. The L. iners strains associated with high bacterial loads and 344 
recurrent sPTB/PPROM in our study may differ from strains associated with lower bacterial 345 
loads. This requires further research.  346 
 347 
Two uncommon taxa (present in fewer than 20% of the women in the low risk group) were 348 
non-significantly associated with early sPTB/PPROM recurrence in our study and were also 349 
associated with PTB in other studies: Ureaplasma
7,24
 and BVAB TM7-H1
6
. In women with 350 
early sPTB/PPROM recurrence, the presence of Ureaplasma species in the vagina did not 351 
completely overlap with having high bacterial loads and lactobacilli concentrations. 352 
Ureaplasma species may therefore play a role in PTB that is independent from overall 353 
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vaginal bacterial composition and load. Our data confirms that Bifidobacterium breve may 354 
have a protective effect against early sPTB/PPROM recurrence.
16
    355 
 356 
Strengths and Limitations 357 
Our study had some limitations, most notably limited statistical power and insufficient data 358 
on vaginal yeasts, but also had strengths. Pregnancy outcomes were very carefully selected 359 
and assessed, many VMB composition variables were created covering different aspects of 360 
VMB composition, and most of these VMB variables were (semi)quantified. The latter turned 361 
out to be crucial, as our most important findings concern bacterial concentrations. The 362 
quantification method that we used has recently been validated for non-minority taxa in two 363 
different studies.
7,8
 We had initially planned to analyse early sPTB and early PPROM as two 364 
separate outcomes because the aetiological pathways may differ,
34
 and to exclude women 365 
who used PTB prevention treatments,
35
 but the limited statistical power did not permit this. 366 
A final limitation is the lack of VMB data in the third trimester and/or closer to the birth. 367 
 368 
Conclusion 369 
Vaginal bacterial load in the second trimester, irrespective of the bacterial composition, was 370 
associated with early sPTB/PPROM recurrence. Domination by lactobacilli other than L. iners 371 
may protect women from developing high bacterial loads. These findings should be 372 
confirmed in larger, longitudinal studies that incorporate quantification of vaginal bacteria 373 
and yeasts. If they are confirmed, interventions that maintain a non-iners lactobacilli/ 374 
bifidobacteria-dominated VMB may protect women from inflammation-associated PTB. 375 
  376 
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Table 1: Participant characteristics by pregnancy risk group and outcome   
Age (years) mean (SD) 31.1 (4.5) 30.0 (4.5) 31.4 (5.4) 0.145 0.211
BMI (kg/m2)¶ median (IQR) 24.5 (22-29) 25 (22-28) 27.5 (22-35) 0.619 0.139
Current smoker¶ number (%) 15 (10.6) 15 (17.4) 5 (23.8) 0.096 0.537
White 139 (95.9) 81 (93.1) 22 (100.0)
Black 3 (2.1) 4 (4.6) 0 0.0
Asian 0 0.0 0 0.0 0 0.0
Other 2 (1.4) 0 0.0 0 0.0
Not recorded 1 (0.1) 2 (2.3) 0 0.0
0 0 0.00 9 (10.34) 1 (4.55)
1 102 (70.34) 43 (49.43) 10 (45.45)
2 36 (24.83) 27 (31.03) 4 (18.18)
≥ 3 7 (4.83) 8 (9.20) 7 (31.82)
1 79 (90.8) 15 (68.2)
≥ 2 8 (9.2) 7 (31.8)
Nil significant 131 (90.3) 79 (90.8) 17 (77.3)
Single LLETZ 14 (9.7) 7 (8.0) 2 (9.1)
Multiple LLETZ or knife cone 1 (1.1) 3 (13.6)
Gestational age at first valid VMB 
sample (weeks)
median and IQR 16+5 (16+2-17+1) 16+2 (16+0-16+6) 16+3 (15+6-17+3) 0.000 0.794
16 weeks 41 (36-47.1) 35.5 (31-42) 36 (26.5-43.5) 0.000 0.578
20 weeks 41 (37-45) 35 (30-40) 30 (26-37) 0.000 0.097
16 weeks 7 (5-16) 7 (5-22) 9 (6-23.5) 0.766 0.410
20 weeks 7 (5-12) 7 (5-14) 7 (6-12) 0.274 0.914
None 139 (100.0) 61 (70.1) 17 (77.3)
Cervical cerclage 4 (4.6) 2 (9.1)
Progesterone 2 (2.3) 1 (4.5)
Arabin pessary 20 (23.0) 2 (9.1)
None 115 (79.3) 65 (74.7) 17 (77.3)
Metronidazole or clindamycin 0 0.0 4 (4.6) 1 (4.5)
Other antibiotic 21 (14.5) 9 (10.3) 3 (13.6)
Clotrimazole 1 (0.7) 0 0.0 0 0.0
Not recorded/ unsure 8 (5.5) 9 (10.3) 1 (4.5)
Gestational age at PPROM (weeks) median and range 31+1 18+0-33+6
Gestational age at birth (weeks) median and range 40+1 (39+0-41+6) 38+6 37+0-41+5 31+5 18+0-35+5
Birthweight¶ (g) mean (SD) 3594 (439) 3234 (489) 1778 (673)
Cervical length¶  (mm)                  
(median and IQR)
qfFN¶ (ng/ml)                                   
(median and IQR)
Term birth n=145 Term birth n=87 Early sPTB or PPROM n=22
Ethnicity (%) 0.540 0.732
Low-risk pregnancy (LR) High-risk pregnancy (HR) P* value LR vs 
HR
P* value HR 
term vs HR 
preterm
Number of previous PPROM or sPTB 
16+0-33+6 weeks (%)
Parity (%) 0.0170.000




Previous cervical surgery na 0.033
na na
Preterm birth prevention treatment 
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Abbreviations: BMI, body mass index; HR, high-risk pregnancy; LR, low-risk pregnancy; na, not applicable; PPROM, preterm prelabour rupture of membranes; qfFN, quantitative foetal fibronectin level in cervicovaginal fluid; 
sPTB, spontaneous preterm birth.  
* P values by Student’s t-test for age,  Mann-Whitney U test for BMI, cervical length, qfFN and gestational age at sampling, and Fisher’s exact test for remainder of variables. 
¶Missing values: BMI 1 each for LR and HR term; smoking 3 for LR, and 1 each for HR term and early preterm; birthweight 2 each for HR term and HR preterm. Cervical length at 16 weeks: HR term n=80, HR preterm n=20, LR 
n=136. Cervical length at 20 weeks: HR term n=79, HR preterm n=14, LR n=135. qfFN at 16 weeks: HR term n=77, HR preterm n=20, LR n=142. qfFN at 20 weeks: HR term n=75, HR preterm n=19, LR n=136.  
=Parity was defined as number of previous pregnancies with live births or stillbirths ≥24
+0




 weeks gestation. Therefore, all HR women 
with parity=0 had at least one previous late miscarriage. Antimicrobial usage was only assessed in the pregnancy prior to sampling. Clotrimazole is available without medical review as an ‘over the counter’ medication in the 
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Table 2:  Associations between VMB variables and recurrent early sPTB/PPROM in high-risk women 
 
n (%) n % n % n % OR 95% CI P
Richness (n) 7 (4-14) 7 (4-15) 7 (4-15) 8 (5-14) 0.35 0.99 (0.93-1.06) 0.785
Simpson diversity (1-D) 0.38 (0.07-0.53) 0.30 (0.06-0.53) 0.39 (0.08-0.54) 0.19 (0.05-0.45) 0.60 0.29 (0.04-2.18) 0.232
Lcr 39 (26.9) 23 (21.1) 17 (19.5) 6 (27.3)
Li 32 (22.1) 36 (33.0) 28 (32.2) 8 (36.4) 0.59 (0.15-2.34) 0.455
Lo+BL 37 (25.5) 22 (20.2) 17 (19.5) 5 (22.7) 0.81 (0.17-3.79) 0.793
LA 18 (12.4) 14 (12.8) 13 (14.9) 1 (4.5) 0.16 (0.01-1.98) 0.154
BV 19 (13.1) 14 (12.8) 12 (13.8) 2 (9.1) 0.48 (0.07-3.24) 0.451
I (L. crispatus) 43 (29.7) 23 (21.1) 17 (19.5) 6 (27.3)
II (L. gasseri) 16 (11.0) 11 (10.1) 9 (10.3) 2 (9.1) 0.38 (0.04-3.95) 0.421
III (L. iners) 31 (21.4) 33 (30.3) 26 (29.9) 7 (31.8) 0.55 (0.13-2.24) 0.402
IV (mixed non Lactos) 35 (24.1) 29 (26.6) 25 (28.7) 4 (18.2) 0.43 (0.09-2.01) 0.287
V (L. jensenii) 20 (13.8) 13 (11.9) 10 (11.5) 3 (13.6) 0.94 (0.17-5.12) 0.944
Lactobacillus  dominance (>75%) 105 (72.4) 80 (73.4) 61 (70.1) 19 (86.4)
Intermediate (25-74.9%) 14 (9.7) 6 (5.5) 5 (5.7) 1 (4.5) 0.91 (0.09-9.36) 0.940
Lactobacillus  deplete (<25%) 26 (17.9) 23 (21.1) 21 (24.1) 2 (9.1) 0.29 (0.05-1.53) 0.140
Same Lactobacilli 83 (64.3) 58 (65.9) 46 (64.8) 12 (70.6)
Different Lactobacilli 3 (2.3) 2 (2.3) 1 (1.4) 1 (5.9) 4.40 (0.19-104) 0.359
Remain non-LD 29 (22.5) 13 (14.8) 12 (16.9) 1 (5.9) 0.42 (0.04-4.11) 0.457
Non-LD to LD 7 (5.4) 10 (11.4) 8 (11.3) 2 (11.8) 0.96 (0.16-5.90) 0.965
LD to non-LD 7 (5.4) 5 (5.7) 4 (5.6) 1 (5.9) 0.41 (0.02-7.21) 0.543
Global assessment Bacterial load 7.68 (6.80-8.35) 145 (100.0) 8.07 (7.28-8.92) 109 (100.0) 7.89 (7.22-8.80) 87 (100.0) 8.64 (7.47-9.08) 22 (100.0) 0.035 1.90 (1.01-3.56) 0.047
Total Lactobacillus 7.31 (6.42-8.01) 143 (98.6) 7.38 (6.76-8.17) 107 (98.2) 7.48 (6.87-8.45) 85 (97.7) 8.59 (7.47-8.87) 22 (100.0) 0.005 2.35 (1.20-4.61) 0.013
Total BV associated 5.41 (1.91-7.03) 109 (75.2) 5.49 (0-7.65) 81 (74.3) 5.20 (0-7.65) 62 (71.3) 6.65 (5.09-8.36) 19 (86.4) 0.102 1.15 (0.96-1.38) 0.126
Total pathobionts 0.00 (0-0) 34 (23.4) 0.00 (0-0) 24 (22.0) 0.00 (0-0) 20 (23.0) 0.00 (0-0) 4 (18.2) 0.596 0.93 (0.712-1.22) 0.596
Total other bacteria 0.00 (0-4.24) 50 (34.5) 0.00 (0-4.93) 45 (41.3) 0.00 (0-4.84) 35 (40.2) 0.00 (0-5.12) 10 (45.5) 0.671 1.04 (0.86-1.25) 0.698
L. crispatus 5.88 (4.41-6.83) 125 (86.2) 6.22 (4.44-6.95) 89 (81.7) 6.17 (4.08-6.91) 71 (81.6) 6.32 (5.79-7.76) 18 (81.8) 0.319 1.02 (0.83-1.25) 0.843
L. iners 4.65 (0-7.14) 82 (56.6) 5.47 (0-7.33) 76 (69.7) 6.55 (0-7.98) 63 (72.4) 7.42 (0-8.81) 13 (59.1) 0.684 0.97 (0.84-1.12) 0.644
Other Lactobacilli 5.49 (3.77-6.91) 125 (86.2) 5.94 (4.24-7.07) 99 (90.8) 5.81 (4.21-7.09) 78 (89.7) 5.95 (5.34-7.61) 21 (95.5) 0.172 1.14 (0.88-1.47) 0.311
1 37 (25.5) 12 (11.0) 11 (12.6) 1 (4.5)
2 36 (24.8) 34 (31.2) 28 (32.2) 6 (27.3)
3 35 (24.1) 18 (16.5) 17 (19.5) 1 (4.5)
4 37 (25.5) 45 (41.3) 31 (35.6) 14 (63.6)
1 36 (24.8) 13 (11.9) 12 (13.8) 1 (4.5)
2 36 (24.8) 25 (22.9) 24 (27.6) 1 (4.5)
3 36 (24.8) 29 (26.6) 23 (26.4) 6 (27.3)














































































Allocation of high risk participants to quartiles of low risk Concentration 
Quartile of total 
bacterial load (n, %)
<6.80




Quartile of total 
Lactobacillus (n, %)
<6.42













































Group according to 
Lactobacillus 
relative abundance   
0.277
Comparator
Stability: change in 
VMB between 16 
and 20 weeks 
gestation-




Low-risk pregnancy (LR) High-risk pregnancy (HR) Adjusted¶ logistic regression 
model of HR ≥ 37 vs <34 weeks 
(n=106)
Birth ≥39 weeks                       
n=145
All high-risk pregnancies               
n=109
Birth ≥37 weeks                       
n=87
sPTB or PPROM <34 weeks            
n=22
p value* difference 
between HR ≥ 37 vs. 
<34 weeksMedian (IQR) Median (IQR) Median (IQR) Median (IQR)
 
 
Abbreviations: HR, high-risk pregnancy; LR, low-risk pregnancy; PPROM, preterm prelabour rupture of membranes; sPTB, spontaneous preterm birth; VMB, vaginal microbiota.  
*P values by Mann-Whitney U test for continuous variables and Fisher's exact test for remainder. ¶Logistic regression adjusted for body mass index as quadratic term, history of cervical surgery (none/single LLETZ/multiple 
LLETZ and/or knife cone biopsy) and smoking (yes/no at time of visit). Adjusted analyses excluded two HR women with missing smoking data, one with missing BMI data, and variable numbers because of collinearity within 
the regression. =VMB type definitions: Li=L. iners-dominated (≥75% lactobacilli with L. iners the most common); Lcr=L. crispatus-dominated (≥75% lactobacilli with L. crispatus the most common); Lo+BL=other lactobacilli- or 
Bifidobacterium dominated (Lo+BL; either≥75% lactobacilli with L. jensenii or L. gasseri the most common, or ≥50% Bifidobacterium); lactobacilli and anaerobes (LA; 25%- 75% lactobacilli); and BV=mixture of BV-anaerobes 
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Table 3: Associations between estimated median concentrations of vaginal bacteria and early recurrent sPTB/PPROM stratified by VMB type 
OR 95% CI P OR 95% CI P
7.75 (6.44-8.46) 7.63 (7.14-8.63) 7.55 (7.14-8.32) 8.20 (7.42-9.06) 1.67 (0.57-4.89) 0.349 1.35 (0.41-4.40) 0.623
Total Lactobacillus 7.73 (6.42-8.46) 7.63 (7.14-8.59) 7.55 (7.14-8.25) 8.20 (7.41-8.86) 1.64 (0.55-4.85) 0.375 1.32 (0.40-4.30) 0.649
Total BV associated 4.74 (0-6.29) 4.62 (0-6.07) 4.29 (0-5.36) 5.24 (0-6.71) 1.09 (0.79-1.50) 0.601 0.87 (0.55-1.36) 0.535
Total pathobionts 0.00 (0-0) 0.00 (0-0) 0.00 (0-0) 0.00 (0-0) 0.93 (0.49-1.75) 0.825 1.07 (0.48-2.39) 0.866
Total other bacteria 0.00 (0-3.19) 0.00 (0-0) 0.00 (0-0) 0.00 (0-0) 1.01 (0.59-1.71) 0.980 0.97 (0.56-1.68) 0.904
L. crispatus 7.72 (6.41-8.45) 7.63 (7.12-8.37) 7.55 (7.12-8.22) 8.19 (7.41-8.80) 1.66 (0.55-5.02) 0.365 1.31 (0.40-4.27) 0.658
L. iners 0.00 (0-4.23) 0.00 (0-4.81) 0.00 (0-5.32) 0.00 (0-0) 0.71 (0.41-1.21) 0.204 0.84 (0.49-1.42) 0.514
Other Lactobacilli 5.09 (3.39-5.94) 5.34 (3.02-7.16) 4.64 (3.02-6.14) 6.20 (5.34-7.39) 1.17 (0.77-1.76) 0.457 1.03 (0.93-1.80) 0.930
7.64 (6.94-8.25) 7.79 (6.93-8.65) 7.79 (6.93-8.65) 9.03 (8.02-9.12) 3.44 (1.06-11.15) 0.040 2.38 (0.71-7.95) 0.160
Total Lactobacillus 7.61 (6.90-8.25) 7.96 (7.23-8.83) 7.79 (6.93-8.60) 8.91 (8.02-9.10) 3.40 (1.04-11.11) 0.042 2.37 (0.70-8.04) 0.165
Total BV associated 4.55 (0-6.37) 5.16 (0-6.60) 4.75 (0-5.79) 6.77 (5.33-7.73) 1.45 (0.98-2.15) 0.061 1.57 (0.95-2.59) 0.079
Total pathobionts 0.00 (0-0) 0.00 (0-0) 0.00 (0-0) 0.00 (0-2.31) 1.21 (0.84-1.74) 0.307 1.15 (0.69-1.91) 0.590
Total other bacteria 0.00 (0-3.61) 0.00 (0-4.26) 0.00 (0-3.38) 4.07 (0-5.69) 1.39 (1.00-1.94) 0.050 1.43 (0.95-2.16) 0.085
L. crispatus 5.89 (3.75-6.60) 6.19 (4.45-6.84) 6.02 (3.83-6.78) 6.38 (6.12-7.79) 1.26 (0.82-1.94) 0.295 1.09 (0.69-1.72) 0.695
L. iners 7.52 (6.90-8.12) 7.93 (7.13-8.79) 7.73 (6.93-8.59) 8.82 (8.02-9.07) 3.35 (1.03-10.86) 0.044 2.33 (0.70-7.76) 0.169
Other Lactobacilli 4.97 0-6.75) 5.59 (4.08-6.59) 5.40 (4.41-7.30) 5.81 (4.08-6.59) 1.20 (0.78-1.85) 0.398 1.06 (0.69-1.63) 0.782
7.12 (6.32-7.69) 7.53 (7.24-8.64) 7.48 (7.21-8.73) 7.64 (7.46-8.61) 1.36 (0.48-3.86) 0.563 3.47 (0.61-19.7) 0.161
Total Lactobacillus 7.12 (6.08-7.69) 7.45 (7.10-8.61) 7.36 (6.94-7.89) 7.61 (7.42-8.61) 1.68 (0.54-5.29) 0.371 5.96 (0.65-54.5) 0.114
Total BV associated 4.64 (0-5.59) 4.29 (0-6.19) 0.00 (0-4.94) 6.36 (6.31-6.58) 1.84 (0.97-3.50) 0.063
Total pathobionts 0.00 (0-2.98) 0.00 (0-4.11) 0.00 (0-4.11) 0.00 (0-0) 0.87 (0.53-1.41) 0.560 0.66 (0.23-1.87) 0.430
Total other bacteria 0.00 (0-5.01) 1.13 (0-5.93) 0.00 (0-5.95) 5.09 (0-5.12) 1.05 (0.76-1.44) 0.769 1.21 (0.77-1.91) 0.410
L. crispatus 5.17 (4.00-5.88) 5.55 (4.44-6.54) 5.52 (5.26-6.54) 5.59 (0-6.16) 0.85 (0.59-1.21) 0.362 0.83 (0.53-1.29) 0.410
L. iners 0.00 (0-6.41) 0.00 (0-7.09) 4.42 (0-7.09) 0.00 (0-0) 0.84 (0.61-1.16) 0.297 0.87 (0.58-1.30) 0.497
Other Lactobacilli 6.99 (5.97-7.51) 7.46 (6.84-8.51) 7.24 (6.93-7.84) 7.61 (7.42-8.30) 1.87 (0.58-6.05) 0.293 8.97 (0.66-121) 0.099
7.93 (7.44-8.52) 8.54 (8.11-9.22) 8.31 (8.07-9.16) 9.15 (9.11-9.28) 9.46 (0.28-318) 0.210 12.42 (0.31-501) 0.182
Total Lactobacillus 6.98 (6.30-7.45) 7.38 (6.63-8.37) 7.25 (6.56-8.19) 8.26 (8.15-8.86) 4.57 (0.54-38.5) 0.162 5.49 (0.17-63.1) 0.172
Total BV associated 7.93 (7.19-8.51) 8.41 (8.07-9.19) 8.18 (8.07-9.15) 9.05 (8.83-9.24) 6.58 (0.33-133) 0.219 9.93 (0.42-237) 0.156
Total pathobionts 0.00 (0-0) 0.00 (0-3.92) 0.00 (0-4.49) 0.00 (0-0)
Total other bacteria 0.00 (0-4.40) 4.57 (0-6.07) 4.59 (0-5.96) 0.00 (0-6.30) 0.83 (0.54-1.28) 0.402 0.70 (0.30-1.62) 0.407
L. crispatus 4.98 (0-5.93) 5.21 (0-6.41) 4.88 (0-6.60) 5.79 (0-5.90) 1.04 (0.69-1.55) 0.859 0.84 (0.48-1.46) 0.537
L. iners 5.65 (0-7.11) 6.68 (4.80-8.21) 6.56 (4.74-7.98) 8.26 (8.15-8.86) 4.74 (0.49-45.6) 0.179 9.82 (0.35-274) 0.179






Low risk pregnancy (LR)
Unadjusted logistic regression model of 
HR ≥ 37 vs <34 weeks (n=109)Birth ≥ 39 weeks n=145 Birth ≥ 37 weeks n=87
sPTB or PPROM <34 weeks  
(early preterm) n=22
Median (IQR) Median (IQR)








































Adjusted* logistic regression model of HR 
≥ 37 vs <34 weeks (n=106)



















 4.0 International license
It is m
ade available under a 
 is the author/funder, w
ho has granted m
edR













he copyright holder for this preprint 







11 January 2021 24 
 
Abbreviations: 95% CI, 95% confidence interval; HR, high-risk pregnancy; IQR, interquartile range; LR, low-risk pregnancy; OR, odds ratio; PPROM, preterm prelabour rupture of membranes; sPTB, spontaneous preterm 
birth; VMB, vaginal microbiota. *Logistic regression adjusted for body mass index as quadratic term, history of cervical surgery (none/single LLETZ/multiple LLETZ and/or knife cone biopsy) and smoking (yes/no at time 
of visit). Adjusted analyses excluded two HR women with missing smoking data, one with missing BMI data, and variable numbers because of collinearity within the regression. Participants were included in these 
analyses even if a taxa was not present in that sample (with concentration=0). ¶VMB type definitions: Li=L. iners-dominated (≥75% lactobacilli with L. iners the most common); Lcr=L. crispatus-dominated (≥75% 
lactobacilli with L. crispatus the most common); Lo+BL=other lactobacilli- or Bifidobacterium dominated (Lo+BL; either≥75% lactobacilli with L. jensenii or L. gasseri the most common, or ≥50% Bifidobacterium); 
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37+0-38+6 (low risk only) 65
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34+0 (low risk only) 2
ated preterm birth 0
ed quality control 9
N=145
Low-risk pregnancy
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